What’s in a name? : the ethical implications and opportunities in diagnosing an infant with neonatal abstinence syndrome (NAS)

Ju Lee Oei, Stacy Blythe, Lauren Dicair, David Didden, Anne Preisz, John Lantos

Research output: Contribution to journalArticlepeer-review

Abstract

Neonatal abstinence syndrome (NAS) is a condition mired in stigma. Diagnostic efforts focus upon the needs of the mother and the clinicians and may sideline and neglect the infant. This results in ‘reflected stigma’ where patients do not receive needed care because we, as clinicians, are too afraid to acknowledge their condition. There is no doubt that NAS, as a diagnosis, is a work in progress but in the meantime, NAS should be used as an opportunity to identify children with a history of prenatal substance exposure so they can receive much-needed early intervention and support, just as any other child in need.
Original languageEnglish
Pages (from-to)4-6
Number of pages3
JournalAddiction
Volume118
Issue number1
DOIs
Publication statusPublished - Jan 2023

Fingerprint

Dive into the research topics of 'What’s in a name? : the ethical implications and opportunities in diagnosing an infant with neonatal abstinence syndrome (NAS)'. Together they form a unique fingerprint.

Cite this